Table 3.
Summary of the distribution and evolution of the clinical signs in the 2 groups of patients.
| Signs | Presence of sign PRE-AS gr 1 | Presence of sign POST-AS gr 1 | Distribution of grades | Distribution of grades |
Average of the grades PRE-AS GR.1 |
Average of the grades POST-AS GR.1 |
P
value |
|---|---|---|---|---|---|---|---|
| Epithelial defect | 100% | 0% | GRADE 3: 73% | GRADE 3: 0% | 2.73 ± 0.46 | 1 | <0.01 |
| GRADE 2: 27% | GRADE 2: 0% | ||||||
| GRADE 1: 0% | GRADE 1: 100% | ||||||
|
| |||||||
| Inflammation | 100% | 14% | GRADE 3: 73% | GRADE 3: 0% | 2.73 ± 0.46 | 1.13 ± 0.35 | <0.01 |
| GRADE 2: 27% | GRADE 2: 13% | ||||||
| GRADE 1: 0% | GRADE 1: 87% | ||||||
|
| |||||||
| Corneal opacity | 100% | 27% | GRADE 3: 84% | GRADE 3: 0% | 2.93 ± 0.26 | 1.40 ± 0.51 | <0.01 |
| GRADE 2: 6% | GRADE 2: 40% | ||||||
| GRADE 1: 0% | GRADE 1: 60% | ||||||
|
| |||||||
| Neovascularization | 60% | 40% | GRADE 3: 33% | GRADE 3: 0% | 1.93 ± 0.88 | 1.20 ± 0.41 | <0.01 |
| GRADE 2: 27% | GRADE 2: 27% | ||||||
| GRADE 1: 40% | GRADE 1: 73% | ||||||
| Epithelial defect | 100% | 0% | GRADE 3: 73% | GRADE 3: 0% | 2.73 ± 0.46 | 1 | <0.01 |
| GRADE 2: 27% | GRADE 2: 0% | ||||||
| GRADE 1: 0% | GRADE 1: 100% | ||||||
|
| |||||||
| Inflammation | 100% | 10% | GRADE 3: 64% | GRADE 3: 0% | 2.64 ± 0.51 | 1.09 ± 0.30 | <0.01 |
| GRADE 2: 36% | GRADE 2: 19% | ||||||
| GRADE 1: 0% | GRADE 1: 81% | ||||||
|
| |||||||
| Corneal opacity | 88% | 28% | GRADE 3: 45% | GRADE 3: 0% | 2.27 ± 0.79 | 1.27 ± 0.47 | <0.01 |
| GRADE 2: 36% | GRADE 2: 45% | ||||||
| GRADE 1: 19% | GRADE 1: 55% | ||||||
|
| |||||||
| Neovascularization | 55% | 45% | GRADE 3: 36% | GRADE 3: 0% | 1.67 ± 0.52 | 1.18 ± 0.40 | <0.01 |
| GRADE 2: 18% | GRADE 2: 27% | ||||||
| GRADE 1: 46% | GRADE 1: 73% | ||||||
Post-AS = postautologous serum treatment; pre-AS = preautologous serum treatment.